Published on 10 May 2024 on Simply Wall St. via Yahoo Finance
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent...
The analysts might have been a bit too bullish on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), given that the company fell short of expectations when it released its quarterly results last week. It was a pretty negative result overall, with revenues of US$30m missing analyst predictions by 6.2%. Worse, the business reported a statutory loss of US$0.05 per share, much larger than the analysts had forecast prior to the result. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
Check out our latest analysis for Rigel Pharmaceuticals
